CA 125 test - Mayo Clinic
COVID-19 Advice updates and vaccine options
Find out about COVID-19, COVID-19 vaccines, and Mayo Clinic patient and visitor updates. Skip to site navigation Skip to Content This content does not have an English version.This content does not have an Arabic version. Search Request an Appointment Find a Doctor Find a Job Give Now Log in to Patient Account English Español العربية 简体中文 Twitter Facebook Pinterest YouTube Menu Request an Appointment Patient Care & Health Information Tests & Procedures CA 125 test
Print Overview
A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in the blood. This test may be used to monitor certain cancers during and after treatment. In some situations, the test may be used to look for early signs of ovarian cancer in people with a very high risk of the disease. A CA 125 test isn't accurate enough to use for ovarian cancer screening in general because many conditions can increase the level of this protein. Conditions that can cause an increase in CA 125 include many that aren't cancerous, such as menstruation and uterine fibroids. Certain cancers may also cause an increased level of CA 125, including ovarian, endometrial, peritoneal and fallopian tube cancers. Products & Services
Book: Mayo Clinic Family Health Book, 5th EditionMayo Clinic Comprehensive Cancer CenterNewsletter: Mayo Clinic Health Letter - Digital EditionShow more products from Mayo Clinic Why it s done
Your health care provider may recommend a CA 125 test for several reasons: To monitor cancer treatment. If you have ovarian, endometrial, peritoneal or fallopian tube cancer, your provider may recommend a CA 125 test on a regular basis to monitor your condition and treatment. But such monitoring hasn't been shown to improve the outcome for those with ovarian cancer, and it might lead to additional and unnecessary rounds of chemotherapy or other treatments. To screen for ovarian cancer if you're at high risk. If you have a strong family history of ovarian cancer or you have an inherited gene that increases the risk of ovarian cancer, your provider may recommend a CA 125 test as one way to screen for this cancer. Some providers may recommend CA 125 testing combined with transvaginal ultrasound every 6 to 12 months for those at very high risk. However, some people with ovarian cancer may not have an increased CA 125 level. And no evidence shows that this screening decreases the chance of dying of ovarian cancer. An elevated level of CA 125 could prompt your provider to put you through unnecessary and possibly harmful tests. To check for cancer recurrence. Rising CA 125 levels may indicate that ovarian cancer has come back after treatment. Regular monitoring of CA 125 has not been shown to improve outcomes for those with ovarian cancer and may lead to additional and unnecessary rounds of chemotherapy or other treatments. If your health care provider suspects that you may have ovarian cancer or another type of cancer, you may undergo additional tests. Other tests that may be helpful in evaluating these cancers include a transvaginal or pelvic ultrasound, serum human epididymis protein 4 (HE4), CT, and MRI. A procedure to remove a sample of cells for testing may be needed to confirm the diagnosis. More Information
Ovarian cancerOvarian cysts How you prepare
If your blood is being tested only for CA 125, you can eat and drink as usual before the test. What you can expect
For a CA 125 test, a member of your health care team takes a sample of blood by inserting a needle into a vein, usually in the hand or arm. The blood sample is sent to a lab for analysis. You can return to your usual activities immediately. Results
The results of your CA 125 test will be provided to your health care provider, who will discuss the results with you. Ask your provider when you can expect to know your results. If your CA 125 level is higher than expected, you may have a condition that isn't cancerous, or the test result could mean that you have ovarian, endometrial, peritoneal or fallopian tube cancer. Your provider may recommend other tests and procedures to determine your diagnosis. If you've been diagnosed with ovarian, endometrial, peritoneal or fallopian tube cancer, a decreasing CA 125 level often indicates that the cancer is responding to treatment. A rising level may indicate a return or continued growth of the cancer. A number of conditions that aren't cancerous can cause an elevated CA 125 level, including: Endometriosis Liver disease Menstruation Pelvic inflammatory disease Pregnancy Uterine fibroids By Mayo Clinic Staff Request an Appointment at Mayo Clinic March 31, 2022 Print Share on: FacebookTwitter Show references CA-125. Testing.com. https://www.testing.com/tests/ca-125/. Accessed Dec. 14, 2021. CA 125 levels: Your guide. Foundation for Women's Cancer. https://www.foundationforwomenscancer.org/gynecologic-cancers/cancer-types/ovarian/. Accessed Dec. 17, 2021. Tumor markers. National Cancer Institute. https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers-fact-sheet. Accessed Dec. 14, 2021. Cancer antigen 125 (CA 125), serum. Mayo Clinical Laboratories. https://www.mayocliniclabs.com/test-catalog/overview/9289#Clinical-and-Interpretive. Accessed Dec. 14, 2021. Ovarian, fallopian tube, and primary peritoneal cancer screening (PDQ) – Patient version. National Cancer Institute. https://www.cancer.gov/types/ovarian/patient/ovarian-screening-pdq#section/all. Accessed Dec. 14, 2021. Zhang M, et al. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. BBA – Reviews on Cancer. 2021; doi:10.1016/j.bbcan.2021.188503. Duska LR. Approach to survivors of epithelial ovarian, fallopian tubal, or peritoneal carcinoma. https://www.uptodate.com/contents/search. Accessed Dec. 14, 2021. Genetic/familial high-risk assessment: Breast and ovarian. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=2&id=1503. Accessed Sept. 7, 2021. Ovarian cancer including fallopian tube cancer and primary peritoneal cancer. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1453. Accessed Sept. 7, 2021. AskMayoExpert. Screening and risk reduction for ovarian cancer. Mayo Clinic; 2021. Related
Ovarian cancer Ovarian cysts Products & Services
Book: Mayo Clinic Family Health Book, 5th Edition Mayo Clinic Comprehensive Cancer Center Newsletter: Mayo Clinic Health Letter - Digital Edition Show more products and services from Mayo Clinic Mayo Clinic in Rochester Minnesota and Mayo Clinic in Phoenix Scottsdale Arizona have been recognized among the top Cancer hospitals in the nation for 2022-2023 by U S News & World Report
Learn more about this top honor CA 125 test
About Advertisement
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission. Advertising & Sponsorship Policy Opportunities Ad Choices Mayo Clinic Press
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press. Mayo Clinic on Incontinence - Mayo Clinic PressMayo Clinic on IncontinenceNEW – The Essential Diabetes Book - Mayo Clinic PressNEW – The Essential Diabetes BookNEW – Mayo Clinic on Hearing and Balance - Mayo Clinic PressNEW – Mayo Clinic on Hearing and BalanceFREE Mayo Clinic Diet Assessment - Mayo Clinic PressFREE Mayo Clinic Diet AssessmentMayo Clinic Health Letter - FREE book - Mayo Clinic PressMayo Clinic Health Letter - FREE book PRC-20393282 Patient Care & Health Information Tests & Procedures CA 125 test